Can Prostate Specific Antigen Be Used as New Biomarker for Early Diagnosis of Breast Cancer?

Can Prostate Specific Antigen Be Used as New Biomarker for Early Diagnosis of Breast Cancer?

Introduction: As a glycoprotein, Plasma Prostate-Specific Antigen (PSA) is mainly produced by prostate epithelial cells and is used as a major diagnostic tool for prostate cancer. A group of researchers relate the elevated number of estrogen receptors in breast cancer samples to the over-production...

Full description

Bibliographic Details
Main Authors:	Seyed Mostafa Shiryazdi, Mohammad Dehestani, Mohammad forat yazdi, Hamid Reza Soltani Gerdfaramarzi, Mansour Moghimi
Format:	Article
Language:	English
Published:	Shahid Sadoughi University of Medical Sciences 2015-09-01
Series:	Journal of Community Health Research
Subjects:	Prostate-Specific Antigen (PSA) Breast cancer Biomarker Early diagnosis
Online Access:	http://jhr.ssu.ac.ir/browse.php?a_code=A-11-1106-1&slc_lang=en&sid=1

Similar Items

Investigation of prostate specific antigen glycosylation
by: MARGITA CUPERLOVIC, et al.
Published: (2000-02-01)

Investigation of prostate specific antigen glycosylation
by: Marinović Vesna, et al.
Published: (2000-01-01)

Prostate-Specific Antigen as an Ultrasensitive Biomarker for Patients with Early Recurrent Prostate Cancer: How Low Shall We Go? A Systematic Review
by: Finn Edler von Eyben, et al.
Published: (2024-04-01)

Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province
by: Sirwan M. Muhammad, et al.
Published: (2013-09-01)

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort
by: R. Jeffrey Karnes, et al.
Published: (2018-08-01)

Prognostic significance of Prostate-Specific Antigen (PSA) rate of change in patients with advanced prostate cancer
by: A E Aghaji, et al.
Published: (2005-01-01)

CLINICAL SIGNIFICANSE OF PROSTATE-SPECIFIC ANTIGEN IN BREAST CANCER PATIENTS
by: N. S. Sergeeva, et al.
Published: (2020-12-01)

Diagnostic Efficacy of grey-zone Serum Prostate Specific Antigen level in patients with Benign Prostatic Hyperplasia and Prostate Carcinoma
by: Syed Atif Hussain, et al.
Published: (2025-01-01)

CUT-OFF VALUES OF PROSTATE SPECIFIC ANTIGEN DENSITY– AN EFFECTIVE SCREENING MARKER BEFORE PROSTATE BIOPSY
by: Zujaja Hina Haroon, et al.
Published: (2022-03-01)

A population study of fasting time and serum prostate-specific antigen (PSA) level
by: Cheryl K Lau, et al.
Published: (2014-10-01)

The effect of lycopene supplement from different sources on prostate specific antigen (PSA): A systematic review and meta-analysis of randomized controlled trials☆
by: Elham Sharifi-Zahabi, et al.
Published: (2022-03-01)

Prostate-Specific Antigen and Time to PSA Nadir as Prognostic Significance in Castration-Resistant Prostate Cancer
by: Firmantya Hadi Pranata, et al.
Published: (2022-03-01)

The role of serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk
by: Cenk Gurbuz, et al.
Published: (2012-12-01)

The diagnostic value of a new formula combining age and prostate volume in prostate cancer
by: Xiaobo Yang, et al.
Published: (2022-02-01)

Value of Systematic and MRI‐Ultrasound Fusion Prostate Biopsy in Different Prostate Specific Antigen (PSA) Levels
by: Solmaz Ohadian Moghadam, et al.
Published: (2025-01-01)

Age-specific reference intervals for Prostate-Specific-Antigen (PSA), its isoform-[-2] pro-PSA (p2PSA) and prostate health index in Indian males
by: Govinda Raju NL, et al.
Published: (2024-04-01)

Prostate-specific antigen (PSA) and distress: - a cross-sectional nationwide survey in men with prostate cancer in Sweden
by: Ulrika Rönningås, et al.
Published: (2019-07-01)

The effect of green tea on prostate specific antigen (PSA): A systematic review and meta-analysis of randomized controlled trials
by: Elham Sharifi-Zahabi, et al.
Published: (2021-03-01)

Prospective investigation of change in the prostate-specific antigens after various urologic procedures
by: Park SC, et al.
Published: (2015-07-01)

Current biomarkers of prostate cancer
by: I. A. Aboian, et al.
Published: (2021-12-01)

Urine biomarkers can predict prostate cancer and PI-RADS score prior to biopsy
by: Blaz Pavlovic, et al.
Published: (2024-08-01)

What Is the Most Appropriate Test in Detecting Prostate Cancer in Patients With Intermediate Prostate Specific Antigen Levels?
by: Hassan Jafari, et al.
Published: (2009-02-01)

Influence of Tumor Burden on Serum Prostate-Specific Antigen in Prostate Cancer Patients Undergoing Radical Prostatectomy
by: Philipp Mandel, et al.
Published: (2021-07-01)

Evaluation of serum PSA levels as a biomarker for breast carcinoma in north Indian females
by: Nikhil Gupta
Published: (2014-05-01)

Association between gleason score, psa level, PSAD and prostate volume, in a series of patients with prostate adenocarcinoma
by: Benedetti-Padrón Inés, et al.
Published: (2012-06-01)

Clinical Issues for Prostate-Specific Antigen Screening: A Narrative Review
by: Marco Randazzo, et al.
Published: (2018-12-01)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
by: Nelson Gianni de Lima, et al.
Published: (2013-06-01)

The clinical relative biological effectiveness and prostate‐specific antigen kinetics of carbon‐ion radiotherapy in low‐risk prostate cancer
by: Yu‐Mei Kang, et al.
Published: (2023-01-01)

Sensitivity and specificity of prostate-specific antigen and its surrogates towards the detection of prostate cancer in sub-Saharan Africa: a systematic review with meta-analysis
by: Chika Juliet Okwor, et al.
Published: (2023-08-01)

SIGNIFICANCE OF DETECTION OF FREE/TOTAL PSA RATIO AND OTHER BIOCHEMICAL PARAMETERS IN PATIENTS WITH BPH, CARCINOMA PROSTATE AND ITS CLINICOPATHOLOGIC CORRELATION
by: S. Joshi, et al.
Published: (2021-11-01)

Is there a non-linear relationship between dietary protein intake and prostate-specific antigen: proof from the national health and nutrition examination survey (2003–2010)
by: Jukun Song, et al.
Published: (2020-05-01)

Toward Maximizing Immunotherapy in Metastatic Castration Resistant Prostate Cancer – Rationale for Combinatorial Approaches Using Chemotherapy
by: Susan F Slovin
Published: (2012-05-01)

Metastatic prostatic adenocarcinoma diagnosed in a bronchoalveolar lavage specimen: An unusual presentation of a common tumor
by: Adrienne E Moul, et al.
Published: (2016-01-01)

Effects of increasing the PSA cutoff to perform additional biomarker tests before prostate biopsy
by: Tobias Nordström, et al.
Published: (2017-10-01)

Towards personalized prostate cancer screening
by: Filella Xavier
Published: (2020-01-01)

Screening for new peptide substrates for the development of albumin binding anticancer pro-drugs that are cleaved by prostate-specific antigen (PSA) to improve the anti tumor efficacy
by: Bakheet E.M. Elsadek, et al.
Published: (2021-07-01)

Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients
by: Samuel W. D. Merriel, et al.
Published: (2022-02-01)

Comparative prostate MRI before and after chronic granulomatous prostatitis following intravesical bacillus Calmette–Guérin therapy
by: Julien Sarkis, et al.
Published: (2021-02-01)

Exposure to heavy metal elements may significantly increase serum prostate-specific antigen levels with overdosed dietary zinc
by: Yinyi Fang, et al.
Published: (2024-03-01)

Aptamers as Theragnostic Tools in Prostate Cancer
by: Carlos David Cruz-Hernández, et al.
Published: (2022-07-01)